Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunogenicity and Efficacy of High-dose Trivalent Inactivated Seasonal Influenza Vaccine (Fluzone High Dose) in Immunocompromised Children and Young Adults.

NCT01685372 is registered in ClinicalTrials.gov with University of Colorado, Denver as lead sponsor.

NCT NCT01685372
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01685372 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunogenicity and Efficacy of High-dose Trivalent Inactivated Seasonal Influenza Vaccine (Fluzone High Dose) in Immunocompromised Children and Young Adults.
Lead sponsor
University of Colorado, Denver
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2012
Completion date
September 30, 2017
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone marrow transplant (bmt), dialysis, human immunodeficiency virus (hiv), rheumatologic disorder, solid organ transplant recipient (liver, kidney, heart)